Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study

Introduction: Up to 27% of individuals undergoing subthalamic nucleus deep brain stimulation (STN-DBS) have a genetic form of Parkinson's disease (PD). Glucocerebrosidase (GBA) mutation carriers, compared to sporadic PD, present with a more aggressive disease, less asymmetry, and fare worse on...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Fabian J., Munoz, Miranda J., Shils, Jay L., Pauciulo, Michael W., Hale, Philip T., Nichols, William C., Afshari, Mitra, Sani, Sepehr, Verhagen Metman, Leo, Corcos, Daniel M., Pal, Gian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514636/
https://www.ncbi.nlm.nih.gov/pubmed/34659089
http://dx.doi.org/10.3389/fneur.2021.723476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514636/
https://www.ncbi.nlm.nih.gov/pubmed/34659089
http://dx.doi.org/10.3389/fneur.2021.723476

Ejemplares similares